Jamaica receives medical support from India in new agreement
India’s pharmaceutical capabilities are reaching new heights – the country is likely to be amongst the highest ranking global markets in value terms by 2020. Indian High Commissioner to Jamaica, His Excellency Sevala Naik said that India has been recognised globally for producing quality medicines at affordable prices.
In line with this, a memorandum of understanding (MOU) is being finalised between Jamaica and India to upgrade the quality of healthcare, medical education and training, and research. The bilateral cooperation will see the exchange and training of medical professionals and facilitate the establishment of healthcare facilities and initiatives for the prevention and control of common non-communicable diseases (NCDs), such as cardiovascular conditions and stroke.
The MOU transpired following talks between Foreign Affairs and Foreign Trade Minister, Senator Kamina Johnson Smith and India’s Minister of Health and Family Welfare, Hon Jagat Prakash Nadda, back in 2017. Minister Johnson Smith said that both the governments of India and Jamaica share an understanding of their respective health challenges and the need to address them.
India has first donated medications valued at US$150,000, to be distributed through the National Health Fund (NHF) and its networks to assist cancer, hypertension and diabetic patients. Health Minister of Jamaica, Dr Christopher Tufton, said the medications will bolster stock and expressed gratitude for the support to Jamaica’s health sector.
Category: Features, Pharmaceuticals
Subscribe
If you enjoyed this article, subscribe to receive more just like it.
